Santosh Kesari
Direttore/Membro del Consiglio presso Curtana Pharmaceuticals, Inc.
Profilo
Santosh Kesari is the founder of Praesidia Biotherapeutics, Inc. He is currently working as a Director at Curtana Pharmaceuticals, Inc.
Posizioni attive di Santosh Kesari
| Società | Posizione | Inizio |
|---|---|---|
Curtana Pharmaceuticals, Inc.
 Curtana Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Curtana Pharmaceuticals, Inc. is a preclinical-stage biopharmaceutical company, which engages in the provision of therapies for the treatment of brain cancer. It focuses on the development of small molecule therapeutics targeting cancer stem cells in the central nervous system for the treatment of glioblastoma and other brain cancers. The company was founded by Gregory Stein in 2013 and is headquartered in Austin, TX. | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Santosh Kesari
| Società | Posizione | Fine |
|---|---|---|
Praesidia Biotherapeutics, Inc.
 Praesidia Biotherapeutics, Inc. Medical/Nursing ServicesHealth Services Praesidia Biotherapeutics, Inc. is a company that specializes in developing drugs using their proprietary Tunable Linker Technology called LESS (Linker Enzyme Substrate System). The company is based in Arlington, MA. This technology helps to maximize the therapeutic potential of drugs. The company was founded by Sohang Chatterjee, Pradip K. Majumder, and Santosh Kesari, with Sohang Chatterjee serving as the CEO since incorporation. | Fondatore | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 2 |
|---|---|
Curtana Pharmaceuticals, Inc.
Curtana Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Curtana Pharmaceuticals, Inc. is a preclinical-stage biopharmaceutical company, which engages in the provision of therapies for the treatment of brain cancer. It focuses on the development of small molecule therapeutics targeting cancer stem cells in the central nervous system for the treatment of glioblastoma and other brain cancers. The company was founded by Gregory Stein in 2013 and is headquartered in Austin, TX. | Health Technology |
Praesidia Biotherapeutics, Inc.
Praesidia Biotherapeutics, Inc. Medical/Nursing ServicesHealth Services Praesidia Biotherapeutics, Inc. is a company that specializes in developing drugs using their proprietary Tunable Linker Technology called LESS (Linker Enzyme Substrate System). The company is based in Arlington, MA. This technology helps to maximize the therapeutic potential of drugs. The company was founded by Sohang Chatterjee, Pradip K. Majumder, and Santosh Kesari, with Sohang Chatterjee serving as the CEO since incorporation. | Health Services |
- Borsa valori
- Insiders
- Santosh Kesari
